General anaesthesia for intralesional bleomycin therapy of vascular malformations: Initial 3 yr experience

British Journal of Anaesthesia

Volumn 102, Issue 3, 2009, Pages 431-432

  Kessell, G ^a   Panchatsharam, S ^a   Kothmann, E ^a   Finn, P ^a   Fall, A ^a   Guhan, A ^a   Muir, T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

CONGENITAL BLOOD VESSEL MALFORMATION; DRUG EFFICACY; GENERAL ANESTHESIA; HUMAN; LARYNGEAL MASK; LETTER; LUNG ALVEOLUS HYPOVENTILATION; LUNG INJURY; NONHUMAN; OXYGEN CONCENTRATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 60249093886     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen395     Document Type: Letter

References (6)

1. Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu G. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 2004; 19: 766-73
2. Pienaar C, Graham R, Geldenhuys S, Hudson DA. Intralesional bleomycin for the treatment of hemangiomas. Plast Reconstr Surg 2006; 117: 221-6
3. Sikic BI. Pulmonary toxicity of bleomycin. Bleomycin Chemotherapy. New York: Academic Press, Inc., 1984; 247-54
4. Goldiner PL, Schweizer O. The hazards of anesthesia and surgery in bleomycin-treated patients. Semin Oncol 1979; 6: 121-4
5. Berend N. The effect of bleomycin and oxygen on rat lung. Pathology 1984; 16: 136-9
6. Shen AS, Haslett C, Feldsein DC, Henson PM, Cherniak RM. Modulation of bleomycin lung injury by short exposure to hyperoxia. Chest 1986; 89: 122S-3S.